v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]      
Revenue $ 8,260 $ 29,053 $ 32,713
Operating expenses:      
Cost of revenues 1,285 911 1,599
Research and development (includes $47,867, $39,780 and $32,400 of share-based compensation expense for the years ended March 31, 2026, 2025 and 2024, respectively) 681,812 550,413 439,909
Acquired in-process research and development 0 0 26,450
General and administrative (includes $298,297, $239,505, and $154,873 of share-based compensation expense for the years ended March 31, 2026, 2025 and 2024, respectively) 610,466 591,410 416,133
Total operating expenses 1,293,563 1,142,734 884,091
Gain on sale of Telavant net assets 0 110,387 5,348,410
Gain on litigation settlement 770,235 0 0
(Loss) income from operations (515,068) (1,003,294) 4,497,032
Change in fair value of investments (105,046) (55,186) 47,973
Change in fair value of liability instruments 47,704 (15,756) 46,838
Gain on deconsolidation of subsidiaries (11,027) (3,108) (32,772)
Interest income (178,109) (258,375) (146,425)
Other (income) expense, net (4,012) 10,721 13,562
(Loss) income from continuing operations before income taxes (264,578) (681,590) 4,567,856
Income tax expense 133,329 48,174 21,503
(Loss) income from continuing operations, net of tax (397,907) (729,764) 4,546,353
Income (loss) from discontinued operations, net of tax 0 373,030 (315,147)
Net (loss) income (397,907) (356,734) 4,231,206
Net loss attributable to noncontrolling interests (98,136) (184,753) (117,720)
Net (loss) income attributable to Roivant Sciences Ltd. (299,771) (171,981) 4,348,926
Amounts attributable to Roivant Sciences Ltd.:      
(Loss) income from continuing operations, net of tax (299,771) (545,166) 4,662,703
Income (loss) from discontinued operations, net of tax 0 373,185 (313,777)
Net (loss) income attributable to Roivant Sciences Ltd. $ (299,771) $ (171,981) $ 4,348,926
Net (loss) income per common share, basic:      
(Loss) income from continuing operations, net of tax (in dollars per share) $ (0.43) $ (0.75) $ 5.95
Income (loss) from discontinued operations, net of tax (in dollars per share) 0 0.51 (0.40)
Net (loss) income (in dollars per share) (0.43) (0.24) 5.55
Net (loss) income per common share, diluted:      
(Loss) income from continuing operations, net of tax (in dollars per share) (0.54) (0.75) 5.61
Income (loss) from discontinued operations, net of tax (in dollars per share) 0 0.51 (0.38)
Net (loss) income (in dollars per share) $ (0.54) $ (0.24) $ 5.23
Weighted average shares outstanding:      
Basic (in shares) 693,864,530 725,395,624 783,248,906
Diluted (in shares) 693,864,530 725,395,624 831,049,444